Uncertainty in T1D Treatment : While CT-868 has demonstrated encouraging results in preclinical studies and early-phase clinical trials in populations with T2D and overweight or obesity, transferring these findings to T1D involves a different pathophysiological context
(The exact reason isnt entirely clearthere could be a metabolic rebound happening in the body or, the simplest explanation, your appetite came back.) Knowing that the weight lost while on a GLP-1 might return, its important to anticipate the modifications you might need to make, and consider some realistic ways to adjust your diet, become more physically active, get enough sleep, and most importantly, take care of your mental health
A well-known GLP-1 RA, semaglutide, is approved by the FDA for the treatment of type 2 diabetes under the brand names Ozempic and Rybelsus
These GLP-1 medications are very effective for weight loss
Noom defines a microdose as a dose of medication that is a fraction 25% or less of the typically prescribed maintenance dose